|
Dexcom Submits 15-Day G7 CGM to FDA for Approval
|
Written by: J. Smith |
Hits: 1830
|
|
Novo Nordisk’s Oral Semaglutide Reduces Cardiovascular Risk by 14% in SOUL Trial
|
Written by: J. Smith |
Hits: 846
|
|
Novo Nordisk Unveils Glucose-Sensitive Insulin to Reduce Hypoglycemia Risk
|
Written by: J. Smith |
Hits: 1480
|
|
FDA Reconsiders Tirzepatide Shortage Status
|
Written by: J. Smith |
Hits: 916
|
|
Teva Launches Authorized Generic of Victoza (liraglutide) in the U.S.
|
Written by: J. Smith |
Hits: 1028
|
|
EU Recommends Wegovy® Label Update for Heart Failure in Obesity
|
Written by: J. Smith |
Hits: 1168
|
|
Innovative Health Research in Space with Dexcom G6 CGM on Polaris Dawn Mission
|
Written by: J. Smith |
Hits: 859
|
|
Lilly Expands Zepbound Access with Single-Dose Vials at Half Price
|
Written by: J. Smith |
Hits: 1394
|
|
FDA Clears Omnipod 5 for Type 2 Diabetes Management
|
Written by: J. Smith |
Hits: 940
|
|
Dexcom Stelo: First Over-the-Counter Glucose Biosensor Now Available in the U.S.
|
Written by: J. Smith |
Hits: 725
|
